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A B S T R A C T :
Long-term drug delivery to the inner ear for neuroprotection might improve the outcome for hearing disabled
patients treated with a cochlear implant (CI). Neurotrophic factor (NTF) producing cells encapsulated in an
alginate-matrix, to shield them from the host immune system and to avoid migration, and applied as viscose
solution or electrode coating could address this requirement. Both application methods were tested for their
feasibility in an artiﬁcial human cochlea model. Since both strategies potentially inﬂuence the electrode im-
plantability, insertion forces and coating stability were analyzed on custom-made electrode arrays. Both, in-
jection of the alginate-cell solution into the model and a manual dip coating of electrode arrays with subsequent
insertion into the model were possible. The insertion forces of coated arrays were reduced by 75% of an un-
coated reference. In contrast, ﬁlling of the model with non-crosslinked alginate-cell solution slightly increased
the insertion forces. A good stability of the coating was observed after ﬁrst insertion (85%) but abrasion in-
creased after multiple insertions (50%). Both application strategies are possible options for cell-induced drug-
delivery to the inner ear, but an alginate-cell coating of CI-electrodes has a great potential to combine an en-
dogenous NTF-source with a strong reduction of insertion forces.
1. Introduction
Worldwide, millions of people suﬀer from sensorineural hearing loss
with negative eﬀects in social, emotional and economic ﬁeld due to a
limited ability of communication (Stevens et al., 2013; Word Health
Organization, 2018). Patients with severe to profound hearing loss can
receive a cochlear implant (CI). The CI consists of an electrode array
which is implanted into the scala tympani of the cochlea for electrical
stimulation of the spiral ganglion neurons (SGN) which subsequently
leads to sound perception in the patient. In hearing impaired patients
the SGN degenerate over time (Glueckert et al., 2005; Nadol et al.,
1989). A high number of stimulated neurons is considered to positively
inﬂuence the outcome of the CI in patients (Landry et al., 2013; Senn
et al., 2017; Seyyedi et al., 2014; Shepherd et al., 2005; Shibata et al.,
2010).
One approach to keep the number of SGN stable is the application of
neurotrophic factors (NTF) like brain-derived neurotrophic factor
(BDNF) (e.g. (Glueckert et al., 2008; Pettingill et al., 2011; Roehm and
Hansen, 2005; Schwieger et al., 2015)). To maintain the beneﬁts of
NTF-treatment on CI-outcome a long-term delivery of the therapeutic
factor is likely to be required (Gillespie et al., 2014, 2003; Pettingill
et al., 2007; Shepherd et al., 2008). Drug delivery systems like in-
tratympanic injections, round window applications, degradable NTF-
eluting coatings, (mini-)osmotic pumps, stem cell or gene therapies of
inner ear cells have either the disadvantages of a short-term application
of the NTFs, or an increased risk of infections or a potentially un-
controlled spread of cells or genes (for overviews, see (Gillespie et al.,
2014; Gillespie and Shepherd, 2005; Liu et al., 2013; Pettingill et al.,
2007)). Nevertheless, cell-based drug delivery strategies have a great
potential for long-term NTF-treatment of SGN. Cells can be genetically
modiﬁed to produce NTF (Harper et al., 2011; Sasaki et al., 2009; Zhao
et al., 2004) and could be provided to the inner ear beside or in con-
junction with the CI during surgery (Konerding et al., 2017; Pettingill
et al., 2011; Rejali et al., 2007; Warnecke et al., 2012). To avoid de-
tachment or migration of the cells and to isolate them from the host
immune system, they can be encapsulated in an alginate matrix
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(Skinner et al., 2009).
Ultra high viscosity (UHV) alginate of medical-grade is particularly
characterized by a high grade of biocompatibility, stability and ﬂex-
ibility. Ba2+-crosslinking of this hydrogel results in a better long-term
mechanical stability (Bajpai and Sharma, 2004; Zimmermann et al.,
2007, 2005), whereas the inﬂammatory response is reduced (De Vos
et al., 1997; Schneider et al., 2003; Tam et al., 2011). An implant
coating with alginate might provide a mechanical buﬀer to protect
sensible surrounding tissue (Abidian and Martin, 2009; Kim et al.,
2010) as well as encapsulated cells (Aguado et al., 2012; Foster et al.,
2017). Regenerated neurites may grow through the hydrogel matrix, to
close the anatomical gap between neurons and electrode. Additionally,
it may act as lubricant for the electrode array to reduce insertion forces
(Kontorinis et al., 2011).
To optimize the CI outcome, the surgical approach, the electrode
array insertion and the electrode design are also in the focus of R&D to
avoid intracochlear trauma (Dhanasingh and Jolly, 2017). An atrau-
matic insertion protecting the structural integrity of soft and bony in-
tracochlear tissue may decrease the risk for inﬂammatory reactions (Bas
et al., 2012; Lehnhardt, 1993; van de Water et al., 2010) or auditory
neuron death, which both could reduce the CI outcome (Bas et al.,
2015; Kikkawa et al., 2014) and the preservation of residual hearing
(Radeloﬀ et al., 2009; Schendzielorz et al., 2014).
For novel electrode generations the development concentrates on
improvement towards thinner and more ﬂexible arrays (Drouillard
et al., 2017; Gnansia et al., 2016; Lenarz et al., 2009; Nguyen et al.,
2013). Additionally, pharmacological functionalization of the electrode
array by drug incorporation or drug-loaded coatings were tested for
their anti-ﬁbrotic eﬀects (Bohl et al., 2012; Farhadi et al., 2013; Wilk
et al., 2016; Wrzeszcz et al., 2014). An analysis of the mechanical eﬀect
of coatings on the insertion process, especially on the insertion forces
(Radeloﬀ et al., 2009; Roemer et al., 2016; Wrzeszcz et al., 2015) and
the stability of the coating after insertion (Ceschi et al., 2014;
Schendzielorz et al., 2014) remained disregarded in most studies.
We propose that a cell-mediated BDNF delivery based on electrode
surface modiﬁcation by UHV-alginate coating can possibly address both
improvement strategies – neuroprotection and insertion force reduction
– for a better CI outcome. Here we investigated UHV-alginate with
encapsulated NTF-producing cells as viscose solution or electrode
coating for its impact on insertion forces. Next to this the coating was
analysed regarding thickness and stability.
2. Materials and methods
2.1. Electrode array fabrication
Commercial CI electrode arrays are very expensive, which may lead
to small sample sizes in experiments. In order to provide a suﬃcient
quantity of samples for insertion experiments, custom-made electrode
arrays (intracochlear length 17.2mm, basal/apical diameter of 0.8/
0.5 mm, tip of 0.2 mm diameter) were fabricated (Hügl et al., 2018).
Their diameter and intracochlear length are compared to the dimen-
sions of electrode arrays from diﬀerent manufacturers in Table 1.
Three marker ribs were included as visual indication of completed
insertion at the end of the conical, intracochlear part of the electrode
array (Fig. 1). A small wing follows after the marker ribs for rotation
identiﬁcation.
For fabrication Sylgard 184 (Dow, Barry, UK), a two-component
silicone for room temperature cure, was used. For better visibility of
arrays and applied coating during insertion and microscopy the silicone
was dyed blue (Silc Pig Blue, Smooth-On Inc., Macungie, USA). Four
bare copper wires of graded length were placed inside the casting
mould before application of the silicone to mimic a stiﬀness gradient
within the array (Hügl et al., 2018). All fabricated arrays were sterilized
by UV-sterilization (1800×100 μJ/cm2, 1800 s; XL-1000 UV cross-
linker, Spectro LinkerTM; Biotec-Fischer, Reiskirchen, Germany) as
preparation for a coating with drug delivering cells.
2.2. Drug delivering cells
Human bone marrow derived mesenchymal stem cells (MSCs) were
chosen as NTF-source and genetically modiﬁed for BDNF-production
and ﬂuorescent marker gene expression (kindly provided by Prof.
Andrea Hoﬀmann, Department of Orthopaedic Surgery, Hannover
Medical School, Hannover, Germany; approved by the ethical com-
mittee of Hannover Medical School, Hannover, Germany, (565–2009,
565–2016)). Cells were maintained under proliferating conditions in
culture ﬂasks at 37 °C and 5% CO2 until used. For the experiments, cells
were detached by addition of trypsin/EDTA solution (0.25%; Biochrom)
for 5min at 37 °C and 5% CO2. Serum-containing medium was used to
stop the trypsinization and cells were resuspended. Subsequently the
number of viable cells was determined by trypan blue exclusion test
(Sigma-Aldrich, Merck KGaA, Darmstadt, Germany) in a Fuchs
Rosenthal chamber (Brand, Wertheim, Germany). The cell suspension
was transferred to a falcon tube (Greiner, Merck KGaA) and centrifuged
for 5min at 800 rpm to obtain an adherent cell pellet. Supernatant was
withdrawn and the cells were resuspended in alginate.
2.3. Alginate-layer formation on electrode-like wires
Platinum/Iridium wires (Sigma Aldrich, Merck KGaA) were cleaned
using argon plasma (kINPen®, neoplas tools GmbH, Greifswald,
Germany) and pre-coated with poly-L-Lysine (pLL (Sigma Aldrich) 1:10
in phosphate-buﬀered saline (Invitrogen, Carlsbad, USA)) for at least
30min. After drying at room temperature, wires were covered stepwise
by (1) dipping into alginate solution, (2) gelling with 20mM BaCl2
cross-linking solution (with 5mM L-histidine and 115mM NaCl, all
chemicals from Sigma-Aldrich) and (3) rinsing in saline (NaCl 0.9%;
B.Braun Melsungen AG, Melsungen, Germany). Diameters of coated
wires were measured manually (Fig. 2 A) after each coating step (Nikon
Instruments GmbH, NIS-elements image analysis software, Duesseldorf,
Germany).
2.4. Coating and embedding of MSC on silicone tubings
The coating of electrodes with alginate and MSCs was simulated and
optimized using silicone tubings. In order to enable the preparation of
cellularized electrodes immediately before application, the coating
procedure was designed with commonly available chemicals and tools.
Silicone tubings were treated with pLL-solution without prior plasma
treatment. After air-drying the silicone's surface was covered with one
layer of UHV-alginate (0.65%, provided by Fraunhofer IBMT, Sulzbach,
Germany; now available from Alginatec GmbH, Riedenheim, Germany)
with suspended cells (> 250,000 cells/ml alginate) and subsequently
cross-linked with 20mM BaCl2 solution. The silicone tubing was dipped
Table 1
Dimensions of custom-made electrode array in comparison to commercially
available straight cochlear implant electrode arrays (Gnansia et al., 2016;
Mistrík et al., 2017; Mom et al., 2016; Oticon medical, 2019).
manufacturer electrode array basal
diameter
(mm)
apical
diameter
(mm)
intracochlear
length (mm)
Advanced Bionics SlimJ 0.56× 0.79 0.26× 0.55 23
Cochlear Ltd. SlimStraight 0.6 0.3 20 - 25
Med-El Flex Soft 1.3 0.5×0.4 31.3
Flex28 0.8 0.5×0.4 28
Flex24 0.8 0.5×0.3 24
Flex20 0.8 0.5×0.3 20
Oticon Medical Classic 1.07 0.5 26
Evo 0.5 0.4 25
This study custom 0.8 0.5 17.2
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in an alginate reservoir with suspended cells and covered by a circular
movement before gelation. Coated silicone tubings were rinsed care-
fully with saline and the procedure was repeated two times.
Subsequently two protecting alginate layers without cells were applied
following the same procedure. Rinsing with saline between the gelation
steps was crucial in order to avoid gelation of alginate in the reservoirs.
After coating the well separated layers were visible on the silicone
tubing (Fig. 2 B). A detailed description of the ﬁnal coating procedure
for human-size custom-made electrode arrays is given in the section
“Electrode array coating”. The stability of the layered coating and
viability of the embedded cells by detection of ﬂuorescent marker gene
expression was tested in vitro for up to three weeks.
2.5. Alginate encapsulated MSC for cochlea model injection
A cell number of 1.5× 106 cells/ml was adjusted and cell suspen-
sion was added to the UHV-alginate in a ratio of 1:6 for a ﬁnal cell
concentration of 250,000 cells/ml. For this concentration a neuropro-
tective eﬀect on SGN is veriﬁed in vitro (Schwieger et al., 2018). The
alginate-cell solution was transferred in a 1ml syringe for application
into the artiﬁcial cochlea model (aCM).
2.6. Electrode array coating
The custom made electrode arrays were dip-coated in layers with
the alginate-cell solution from tip to marker ribs under sterile condi-
tions (Fig. 3). First, arrays were pre-coated with poly-L-Lysine solution
(pLL (Sigma Aldrich) 1:10 in Ca2+/Mg2+-free PBS (phosphate-buﬀered
saline) (Invitrogen, Carlsbad, USA)) for 40–50min, with a subsequent
drying step at room temperature. For the inner cell containing layers of
the coating a mean of∼400,000 cells (±∼125,000) was embedded in
500 μl alginate as dipping-solution. Each alginate layer was gelled by
ionic crosslinking for 20 s and crosslinking agent was washed out by
rinsing in saline (NaCl 0.9%; B.Braun Melsungen AG) before next layer
was applied. Crosslinking solution was composed of 20mM BaCl2
(Sigma Aldrich), 115mM NaCl (Roth, Karlsruhe, Germany) and 5mM
L-histidine (Genaxxo bioscience, Ulm, Germany) and adjusted to a pH
of 7 before ﬁltered for sterility (Gepp et al., 2009; Hütten et al., 2013).
To apply inner cell-containing alginate layers arrays were dipped four
times in the cell solution followed by apply of three outer layers of pure
alginate to cover the cell containing inner layers. Each layer formation
was monitored under microscopic control. After formation of the last
free alginate layer, a ﬁnal gelation was performed for 5min with
subsequent photo documentation of each coated array (Fig. 3, A).
2.7. Water contact angle measurement
The surface conditions of an implant can inﬂuence the implantation
properties and inﬂammation reactions. For example silicone has the
disadvantage of hydrophobicity and a tendency for protein, cell and
bacteria adhesion. Therefore, the inﬂuence of the coating is tested for
its impact on the wettability of silicone. Four diﬀerent materials were
tested by water contact angle measurement. Round disks of silicone
without (clear silicone) and with blue dye (dyed silicone) were fabri-
cated from the same two-component silicone material, which was
previously used for array fabrication. Mixing of the two components
and curing was conducted as described above. A slice of dyed silicone
and a cover glass (Ø 30mm, Menzel GmbH, Braunschweig, Germany)
were dip coated with two layers of UHV-alginate as described above.
The coated silicone disk and cover glass were stored in saline until
tested. Water contact angle measurements were performed and ana-
lyzed with the Surftens Universal and associated software (OEG,
Frankfurt, Germany; kindly provided by AG Behrens, Leibniz University
Hannover). Three diﬀerent positions were tested on each material
sample and the contact angle measurements of a deionized water dro-
plet were repeated in triplicate and averaged. Before alginate-coated
silicone and cover glass were placed on the device, saline was drained
and residual ﬂuids at the edge were carefully dabbed. After 2min of air
drying, measurements were performed. To exclude an inﬂuence of
possibly remaining sodium chloride crystals on the droplet formation,
coated samples were shortly rinsed with deionized water, residual ﬂuid
was removed as described before and the contact angle measurements
were repeated.
2.8. Experimental groups & insertion setup and procedure
Custom-made electrode arrays were inserted in three diﬀerent ways
(Table 2) into an aCM (Fig. 5) and examined for their insertion forces.
Each combination is thereinafter referred to as group, where each group
comprised 20 arrays (see Table 2).
To enable standardized and reproducible insertions, an automated
insertion test bench was used, which was previously developed and
described in detail (Hügl et al., 2018). In short, this setup comprised a
linear stage onto which surgical forceps were mounted for gripping and
movement of the arrays. They were inserted into a custom-made, planar
aCM milled from Polytetraﬂuoroethylene (PTFE) and covered with
Fig. 1. Schematic drawing of a custom-made electrode
array with functional measures in mm.
Fig. 2. (A) Stepwise coating of Pt–Ir wires with UHV-al-
ginate hydrogel, given as wire diameter plus applied
surrounding coating measured after each coating cycle.
After repeated cycles a multilayer of alginate of ap-
proximately 60 μm is covering the wire's surface. (B)
Coating of silicone tubings with cells and a protecting
alginate layer. The protecting alginate layer avoids re-
lease of cells during cultivation and is stable for the tested
time period (three weeks). Scale bar in (B): 200 μm.
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acrylic glass to enable a direct view of the array during insertion. The
aCM was mounted on a force sensor (K3D35, ME-Meßsysteme GmbH,
Hennigsdorf, Germany; 0.5 N nominal force, accuracy class 2%) and
aligned to the movement axis of the linear stage. A microscopic camera
was used for documentation of the insertion procedure. The linear stage
and the force sensor were connected to a personal computer on which a
custom-made software (developed using C++; Visual Studio, 2015;
Microsoft Corporation, Redmond, Washington, USA) was run for in-
sertion controlling and force measurement.
A total of 60 electrode arrays were used in three groups (Table 2):
Each array was inserted three times, resulting in 60 insertions for each
group. Reproducible insertion forces with repeated insertion of one
array were checked previously (Hügl et al., 2018).
Calibration of the force sensor was veriﬁed before a new group of
arrays was inserted (5 g and 20 g, class M1 knob weights, Häfner
Gewichte GmbH, Oberrot, Germany). Afterwards the acrylic disk was
mounted on the PTFE-base of the aCM and the cavity was ﬁlled with
saline (Kontorinis et al., 2012; Leon et al., 2018; Nguyen et al., 2012).
Arrays of the reference group (group 1) were gripped at marker ribs
using surgical forceps whereby their tip hung into the opening of the
aCM and were then automatically inserted for 15.5 mm with an inser-
tion speed of 0.4 mm/s. For group 2, the aCM was ﬁlled with saline
followed by application of viscose, non-crosslinked alginate-cell solu-
tion through a curved hollow needle, which thereby partly displaced
the saline. Finally uncoated arrays were inserted. In group 3, the aCM
was ﬁlled with saline and alginate-cell-coated arrays were inserted. To
remove any detached coating, the aCM was ﬂushed and reﬁlled with
saline after each insertion of a coated array.
2.9. Thickness of coating and classiﬁcation of abrasion/delamination
Each part of the coated arrays was documented by sectionwise
photographing. Arrays were ﬁxed with their wing upright, to enable
comparable positioning and orientation in the pictures. Pictures were
taken with a digital color camera (Olympus XC30, Hamburg, Germany)
connected to an inverse microscope (Olympus CKX 41, Hamburg,
Germany) using the 1.25-objectiv. Subsequently pictures were merged
(Adobe Photoshop CS5) to depict the entire array. All coated arrays
were documented at the end of the coating procedure, after the ﬁrst
insertion into the aCM, investigating the inﬂuence of a single insertion
(comparable to the surgical procedure in patients) and after the third
insertion for worst-case evaluation. The thickness of the coating was
analyzed on pictures taken before the ﬁrst insertion using Cell-D soft-
ware (Olympus Life Science, Waltham, USA). The thickness above and
below the array at the basal (Fig. 4, A) and apical (tip; Fig. 4, B) 3mm
of the carrier was measured between the surfaces of the array and the
outermost alginate layer (Fig. 4, red lines) and data were averaged.
Hereby a possible inhomogeneity of the coating based on alginate rin-
sing downwards to the tip of the array could be documented.
For the classiﬁcation of the coating-stability after insertion, the
merged photographs (Fig. 3, B) of the coated electrode arrays were
assessed by three persons and results were averaged. The abrasion of
the coating was classiﬁed in six diﬀerent grades (Table 3).
3. Results
3.1. Insertion forces
The arrays in group 1 (reference group: aCM ﬁlled with saline) and
group 2 (lubricant group: alginate-cell solution as lubricant for inser-
tion in about 70% (26mm3) of basal turn of the aCM) showed
Fig. 3. Coated human-sized custom-made electrode ar-
rays with (A) inner cell-containing (spotted, white ar-
rows) and outer cell-free (transparent, black arrows) al-
ginate layers. A droplet formation at the tip with
increased coating thickness is often noticeable (circle).
Single pictures of the array sections were assembled for
evaluation of the whole arrays. (B) depicts an example for
abrasion with delamination of cell containing coating
layers (black arrow heads) scored to grade 5. The images
exemplify the contrast enhancement between the trans-
parent alginate layers and the array achieved by blue
coloring of the silicone. Triangles point at the marker
ribs. Scale bar: 1000 μm.
Table 2
Experimental groups.
Cochlea model ﬁlling Electrode array coating Sample size
Group 1: Reference saline no 20
Group 2: Lubricant saline + non-crosslinked alginate encapsulated cells no 20
Group 3: Coating saline crosslinked alginate encapsulated cells 20
Table 3
Grades of abrasion of coated arrays.
Grade Abrasion of coating
0 no abrasion
1 minimal abrasion on max. ½ of array
2 minimal abrasion on > ½ of array
3 moderate abrasion on max. ½ of array
4 moderate abrasion on > ½ of array
5 severe to complete abrasion
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considerable occurrences of buckling and tip fold-over. In such case the
movement was stopped leading to an incomplete insertion and corre-
sponding force measurements were excluded from evaluation, resulting
in 23, respectively 26, analysed insertions. Group 3 (coated arrays)
showed neither buckling nor tip fold-over, so that all 60 insertions were
successful and included in analysis.
Analysis was performed with data of successful (without tip fold
over or buckling) and complete (from tip to marker ribs) insertions
(Fig. 5). The maximal forces occurred at the very end of the insertion
process (15.5 mm) and tended to be lower in the reference group
(92.9 ± 46.6 mN) than in the lubricant group (107.8 ± 49.0 mN)
(Figs. 5 and 6). Lowest forces at the very end of the insertion were
measured for coated arrays with 12.6 ± 6.5mN (Fig. 5). Compared to
the other groups, maximal insertion forces of the coated arrays occur
earlier during insertion, at an insertion depth of only
15.39 ± 0.02mm. At this section forces of 15.4 ± 8.5mN were
achieved. Due to the observed abrasion of the coating in some arrays,
the maximal insertion forces were evaluated again, diﬀerentiated for
the ﬁrst and the third insertion of the arrays. The mean overall maximal
insertion forces, regardless of the occurring position, for the ﬁrst in-
sertion of the coated arrays was found to be 23.3 ± 8.2mN, and
22.9 ± 7.5mN for the third insertion (diﬀerence not signiﬁcant,
Mann-Whitney-U-Test, α=0.05; Fig. 6).
Comparing the maximal insertion forces of the reference group to
those of the alginate coated arrays a signiﬁcant reduction of 75.2%
(Mann-Whitney-U-Test, α=0.001) can be shown (Fig. 6, A). As there is
no relevant diﬀerence in maximal forces of ﬁrst and third insertion of
the coated arrays (Fig. 6, B), the partly observed abrasion of the coating
does not seem to have an impact on insertion force.
3.2. Coating procedure, mechanical robustness and wettability
A coating mediated by pLL with pure UHV-alginate as well as with
UHV-alginate encapsulated cells in layers was applicable to platinum,
silicone and human-size custom-made electrode arrays. The coating
was generally homogenous and a smooth surface was formed. In vitro,
the layered coating was stable in medium for the observed three weeks
and the embedded cells still expressed the ﬂuorescent marker gene. Due
to the manual dip coating procedure, there was a variability in the
thickness of the applied alginate layers on the wires (Fig. 2, A) and also
of the coating of the electrode arrays. The analyzed basal part had a
mean thickness of 0.12mm varying between 0.01 and 0.35mm with no
diﬀerences observed within the analyzed array length. For the apical
part of the coated arrays an averaged thickness of 0.22mm above and
below the array was measured with no diﬀerence within the 3mm
analyzed. The apical coating thickness varied between 0.03 and
0.85mm. Overall the coating was thinner on the basal part compared to
the apical part, due to varying degree of droplet formation on the array-
tip.
Occasionally some loose fragments of the outermost alginate layer
were seen after ﬁnal linkage. Nevertheless, the coating on the arrays
was robust and ﬂexible enough for the insertion procedure including a
positioning of the tip within the opening of the aCM using forceps. Even
a gentle straightening of bended coated array-tips by forceps after in-
sertion for a correct positioning for the next insertion was possible
without a visible abrasion of the coating.
After the ﬁrst insertion, no coated array was classiﬁed to grade 5
with severe or complete abrasion of the coating (Fig. 7, A). 85% (17 out
of 20) of the analyzed arrays had no to minimal signs of coating
abrasion (grade 0–1). The remaining 15% (3 out of 20) were equally
distributed to grade 2 to 4. In contrast, after the third insertion a re-
duction of the coating stability was detectable (Fig. 7, B). 40% (8 out of
20) of the coated arrays were rated to grade 5 and 4 and the number of
arrays having a coating still remaining intact or nearly intact (grade
0–1) was reduced to 50% (10 out of 20). 5% (1 out of 20) of the coated
arrays were classiﬁed to grade 2 and 3 each. During evaluation of the
degree of abrasion, there was no visible interrelation between coating
thickness and impact of abrasion detectable.
Materials with water contact angles of< 90° are classiﬁed as hy-
drophilic with a high wettability, while contact angles of> 90° corre-
spond to hydrophobic surfaces with a low wettability (Bracco and
Holst, 2013). Both bare silicone disks (representing the silicone surface
of uncoated electrode arrays) were clearly hydrophobic with water
Fig. 4. Light microscopic image of the coated basal part
(A) and the tip (B). Coating thickness is measured at the
basal and apical 3mm (yellow). Thickness is measured at
these three points as distance (red line) between the
surface of the array to the surface of the outmost alginate
layer above and below the array. Triangle points at the
marker rib at the basal part of the array. Scale bar:
1000 μm.
Fig. 5. Exemplarily shown insertion of a coated electrode array into the aCM
(a-c). The ﬁrst contact between the array and the aCM occurs at its outer wall
(◄). The second contact occurs at the inner wall of the aCM (◄◄), after which
point the array bends to follow the curved path of the aCM. Final insertion
position, with marked ending of the ﬁrst (−), the second (=) and the last two
(≡) embedded copper wires. Occurrences of buckling (rectangle in d) and tip
fold over (circle in e) are shown for completeness. Insertion forces of all three
investigated groups as function of insertion depth and their standard deviations
(SD). Positions (a), (b) and (c) within the insertion force diagram correspond to
the small images above.
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contact angles of 115.2° ± 1.8° (clear silicone) and 116.2°± 0.8°
(dyed silicone). In contrast, the alginate-coating of silicone and cover
glass had a highly hydrophilic eﬀect. The droplet for contact angle
measurement immediately spread on both coated materials, after rin-
sing with deionized water as well. No droplet was formed for angle
measurements (0°, complete wetting).
4. Discussion
In this study, two UHV-alginate-cell-based drug delivery strategies
were tested for their feasibility to improve CI therapy. Using a human-
sized aCM, their applicability and their inﬂuence on the insertion forces
into the model were tested.
The experimental setup with custom-made electrode arrays and
saline ﬁlled aCM can mimic a CI-insertion surgery only to a limited
extent. For example the friction conditions while inserting an electrode
array into a living cochlea may diﬀer from the conditions of an aCM
ﬁlled with an artiﬁcial ﬂuid. Previously we were able to show that
ﬁlling the aCM with saline shows very good correspondence of insertion
forces when compared to fresh porcine specimen (Salcher et al., 2019).
Therefore, we can state that the aCM used in the present study is an
adequate artiﬁcial model for the human cochlea. The custom-made
electrode arrays used within the study are straight arrays with dimen-
sions similar to those of commercially used ones (see Table 1). With the
Slim Straight (0.6–0.3mm diameter; Cochlear Ltd.) and the Evo array
(0.5–0.4 mm; Oticon Medical), only two straight electrode arrays are
considerably smaller in diameter than the custom-made ones used in
this study.
UHV-alginate as hydrogel matrix was chosen because of its above-
mentioned desirable characteristics for an application in the inner ear.
The BaCl2-crosslinked UHV-alginate can tie encapsulated drug-produ-
cing cells for long-term drug delivery and shield them against the host
immune system. The biocompatibility and high stability of crosslinked
alginate in vivo has been demonstrated in several studies (e.g. (Elliott
et al., 2007; Skinner et al., 2009; Wise et al., 2011; Zimmermann et al.,
2005)). Additionally cells encapsulated in alginate can be protected
against shear stress (Aguado et al., 2012; Foster et al., 2017), which is
advantageous since high shear stress during an application of cells can
damage the cell membrane and result in decreased cell survival. Thus,
we assume a better protection of the encapsulated cells during insertion
but did not focus on cell viability in the presented study. When applied
as coating, the alginate creates a ﬂexible, mechanically soft surface and
shields the hydrophobic silicone of the CI-electrode (Abidian and
Martin, 2009; Kim et al., 2010).
A supply of viscose alginate-cell solution for application to the inner
ear could be easily included during surgical procedure and has the
potential for CI improvement. Senn et al. (2017) were able to proof the
concept of a gapless interface for the CI in an animal model. Neurites
were regenerated under NTF-treatment through an injected functiona-
lized gel-nanomatrix for structural support in the scala tympani. In the
here presented study, we modiﬁed Senns approach of using hydrogel-
injection for neurite outgrowth towards the CI onto a cell-based drug
delivery system. We could proof the possibility to encapsulate NTF-
producing cells in medical grade alginate under sterile conditions.
Within approximately 30min cells were detached, encapsulated and
ﬁlled into a syringe ready for inner ear injection.
The measured insertion forces within our study increased slightly,
although not signiﬁcantly, when arrays were inserted into the alginate-
cell solution ﬁlled aCM compared to an insertion into saline (reference).
This is in contrast to a signiﬁcant reduction of insertion forces for 50%
and 75% BaCl2-crosslinked alginate we detected previously (Kontorinis
et al., 2012). An explanation would be that the insertion was performed
in a by the liquid BaCl2 for 50% and 75% diluted and not yet cross-
linked alginate. In our current study, the UHV-alginate was mixed with
∼17% cell suspension and was therefore less diluted and included cells,
what may have caused higher insertion forces compared to saline.
The dip coating of pLL-precoated platinum wires, silicone tubings
and ﬁnally the human-size custom-made electrode array was performed
manually under sterile conditions and was tested stable in vitro for at
least three weeks. A layer-by-layer application of (four) inner cell-
containing and (three) outer cell-free isolating alginate layers was
possible and easy to apply. The electrode arrays were completely cov-
ered with the coating from base to tip. Because of the manual proce-
dure, each layer was individually formed, resulting in an increased
standard deviation after each coating cycle. The measured thickness of
the coating at the basal part of the custom-made arrays had a mean
thickness of 0.12mm, which increased to 0.22mm (max 0.85mm) at
the apical part. The coating of our arrays increased its volume by
Fig. 6. Maximal insertion forces. The diﬀerence between
forces of reference and lubricant group to coated group
was signiﬁcant (Mann-Whitney-U-Test, α=0.001). The
mean insertion force of the reference did not diﬀer sig-
niﬁcantly from that of the lubricant group (A). Insertions
forces for ﬁrst (median 21.4mN) and third insertion
(median 22.6mN) of coated arrays showed no signiﬁcant
diﬀerence (B).
Fig. 7. (A) Coating stability after ﬁrst insertion. 85% of
the tested electrode arrays had no or only minimal signs
of coating abrasion (grade 0–1). (B) When insertion into
the aCM was repeated, the impact on the coating and
therefore the abrasion was increased. 50% of the arrays
were classiﬁed to higher grades (2–5) of abrasion after
the third insertion, while 50% still had no or only
minimal signs of coating abrasion (grade 0–1) (B).
N=20.
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approximately 20%. This has to be considered for implantation surgery
e.g. in term of intra cochlear pressure increase and perilymph dis-
placement (Mittmann et al., 2017; Roland, 2005). Since there was no
high deviation in the insertion forces between arrays with varying
coating thicknesses and no distinct diﬀerence for the ﬁrst compared to
the third insertion, it is assumed that also a much thinner coating might
be valuable for the advantageous force reduction. The observed droplet
formation at the apical tip of the array during manual dip coating could
additionally reduce the potential for insertion trauma by distribution of
insertion forces (Bhatti et al., 2015). Although the thickness of our al-
ginate coating varied widely due to the manual dip coating procedure
and the coating was partly rubbed oﬀ some arrays, none of the coated
arrays showed buckling or tip fold-over during insertion, while both
occurred in the groups without coating. This indicates that an alginate
coating (independent of its thickness) might have the potential to re-
duce the incidence of buckling and tip fold-over. Reasons for this could
be a reduction of the friction on the cochlea wall and the modiolus, a
function as mechanical buﬀer, the named better distribution of inser-
tion forces and a stabilization of a soft tip without a critical impact on
the ﬂexibility.
A mostly homogenous coating with a smooth surface was applicable
by the described dip coating procedure. Rarely some loose parts of the
outermost alginate layer were seen without any detectable negative
inﬂuence on the insertion. However, a proper adherence to the array
and a high level of ﬂexibility, a prerequisite for insertion, were
achieved like requested in Schendzielorz et al., (2014).
The stability of the here presented coating was good at initial but
decreased with repeated insertions. There was no visible indication that
the diﬀerent thicknesses of the applied coating had an inﬂuence on the
stability during insertion. After the ﬁrst insertion, comparable with CI-
electrode implantation surgery in patients, 15% showed signs of
minimal or moderate abrasion of the coating. This good stability of the
coating decreased with repeated insertions. After the third insertion
half of the coated arrays had an (nearly) intact coating, while one ﬁfth
showed severe delamination of the coating. In a previous study we
documented a removal of CI-electrode-covering ﬁbroblasts from the
outer electrode surface after ﬁrst insertion into a cochlea model but no
increased removal after ﬁve repeated insertions (Kontorinis et al.,
2012). We hypothesized that this result might be due to a complete
detachment of all formally attached cells contacting the outer wall
during ﬁrst insertion into the model. In comparison, the here tested
coating is composed of several layers for more stability and especially to
avoid a detachment and migration of cells. But the careful straightening
of bent arrays by forceps for a correct insertion, the repeated insertions
and the handling for photo documentation may have had negative
impact on the stability of the alginate-coating in comparison to studies
presenting a complete stability of coatings (Hassarati et al., 2014;
Schendzielorz et al., 2014). For insertion surgery of an alginate-cell-
coated CI a more stable adherence of the tested coating is expected due
to less handling. A further improvement of the coating stability could
possibly be achieved by: a reduction of applied layers (requiring an
increased number of encapsulated cells at the same time) or a func-
tionalization of the interface between the single layers (Ehrhart et al.,
2013) or the incorporation of microﬁbers into the hydrogel or the usage
of a stiﬀer UHV-alginate (e.g. “high-G″ alginates, composed of more
guluronic acid units or an increased time of ﬁnal crosslinkage, with
consideration of a negative inﬂuence on cell viability). Otherwise the
presented results prove already a relatively good robustness of this
simple and gentle cell encapsulating coating, even against handling
with surgical instruments since there was no severe impact on most
coated electrodes after straightening and positioning by forceps espe-
cially after the ﬁrst insertion. Nevertheless, in vivo studies proved a
good stability for implanted cells encapsulated in hydrogel, especially
in UHV-alginate, for example for 6 months (Skinner et al., 2009; Wise
et al., 2011) to 9.5 years (Elliott et al., 2007). Therefore, an abrasion of
the coating with the encapsulated cells does not necessarily induce a
decrease in safety or biocompatibility of this cell-based drug delivery
systems in contrast to cell-seeded implants without a coverage of the
cells (Kontorinis et al., 2012; Roemer et al., 2016; Schendzielorz et al.,
2018; Warnecke et al., 2012).
The impact of the alginate-cell coating on the insertion forces was
tested in an aCM. In previous studies inconsistent results are reported
for insertion forces of coated electrodes ranging from no diﬀerence
(ﬁbrin glue coating) (Roemer et al., 2016) over a slight but not sig-
niﬁcant increase (collagen and ﬁbrin coating) (Schendzielorz et al.,
2014) to an signiﬁcant increase (star-shaped polyethylene glycol pre-
polymer-hydrogel coating of electrode array equivalent implants (op-
tical ﬁbres)) (Wrzeszcz et al., 2015). These results reinforce the position
of the authors, whereby an assessment of a coating for drug delivery
purposes based only on pharmacological aspects, like drug elution rate,
is not suﬃcient to assess the feasibility of such a coating for clinical
application since the mechanical implantability may be negatively af-
fected (as stated in Wrzeszcz et al., 2015).
A coating of electrodes with ﬁbroblasts halved the insertion forces
compared to uncoated electrodes, whereby the cells were rubbed oﬀ the
electrode during insertion (Kontorinis et al., 2012). There was no in-
crease in forces when reinserting the partially cell-covered arrays,
maybe due to remaining cells at the outer wall of the cochlea model
facilitating further insertions. In the here presented study the aCM was
ﬂushed after each insertion of the coated array to exclude inﬂuences of
detached alginate on the forces of following insertions. There was no
diﬀerence in the measured insertion forces between ﬁrst and following
insertions of the same array, even when the coating was partly rubbed
oﬀ. Therefore, it can be assumed that the reduction in the forces is a
direct eﬀect of the alginate coating, regardless of the coating thickness.
A slight but not signiﬁcant decrease of insertion forces for poly-
dopamine-cell coated electrodes with a few detached cells during in-
sertion as well was documented by Schendzielorz et al. (2018). Another
study analyzed the impact of a ﬂexible, biodegradable coating based of
hydroxyl-ethyl-cellulose applied to prototype arrays on the insertion
forces into a cochlea model (Radeloﬀ et al., 2009). A signiﬁcant average
reduction of forces exceeding 50% compared to uncoated arrays was
veriﬁed. Additionally, a less erratic and therefore smoother insertion
into the model was detected for the coated arrays. In contrast buckling
was frequently seen in the group of uncoated arrays, which both is in
accordance with our results.
We assume that our detected reduction of the insertion forces and
smoother insertion into the artiﬁcial cochlea model is mainly based on
the hydrophilic character of the tested alginate-coating. A water contact
angle of about 0° for the alginate coated surfaces compared to contact
angles of 115.2°± 1.8° (clear silicone) and 116.2°± 0.8° (dyed sili-
cone) for the uncoated silicone samples indicates the massive increase
of hydrophilicity by the alginate-coating. Some disadvantages of sili-
cone as material for CI electrodes are the native hydrophobicity, high
friction and a bacterial and protein adhesive tendency (Kinoshita et al.,
2015). Some in vivo studies showed that a hydrophilic coating of elec-
trodes caused a better implantability, lower ﬁbrous tissue formation
and protection of hair cells and SGN (Kikkawa et al., 2014; Kinoshita
et al., 2015). This was attributed to a reduction of insertion trauma
during surgery. Both studies did not detect insertion forces. But one can
speculate about an association between hydrophilic coatings of the si-
licone electrodes, our detected reduced insertion forces and a reduction
of insertion trauma with a protection of hair cells and SGN. Therefore,
we assume that the here presented hydrophilic UHV-alginate coating of
the electrode array with the purpose of chronic endogenous cell-based
drug delivery may have additional beneﬁcial eﬀects for the CI outcome
by reducing surgically-induced trauma, foreign body reaction and
protecting inner ear tissue and residual hearing.
5. Conclusions
Alginate ﬁlling of the scala tympani might be an option to bridge the
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distance between the electrode contact and the regenerating peripheral
dendrites of the spiral ganglion neurons and provide the necessary
extracellular matrix to guide the dendrites towards the electrode con-
tact following the gradient of NTFs secreted from the coated electrode.
But changes in the scala tympani ﬂuids and the detected higher inser-
tion forces would limit this drug delivery system to patients without
residual hearing. In contrast, the presented results of the alginate-cell-
coated CI-electrodes indicate feasibility, especially for patients with
residual hearing, combining the potential for long-term local drug de-
livery with an eminent reduction of the insertion forces. Therefore, this
electrode array functionalization is a very promising candidate as drug
delivery system for inner ear therapy with an expected reduced trauma
during CI surgery and a high potential for improvement of hearing
outcome. Beside drug delivery, the results also open up new opportu-
nities for application of a pure alginate coating to positively inﬂuence
implantation behavior of CI-electrodes by reduction of insertion forces.
This study detected forces in an aCM, which can mimic the forces of
a CI inserted into a living cochlea only to a limited intent. Therefore,
human temporal bone studies and preclinical in vivo studies should be
performed to give a deeper insight into a reduction of the forces and a
protection of the delicate intracochlear structures during insertion of an
alginate-cell-coated CI. Further investigations have to focus on an ad-
ditional improvement of the uniformity of the coating and the stability
during insertion. Also the eﬀects of coated electrodes with and without
cells regarding intracochlear pressure, impedance changes and safe
charge delivery capabilities have to be examined.
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